Haleon (LON:HLN) Shares Up 0.4% – What’s Next?

Shares of Haleon plc (LON:HLN) shot up 0.4% during trading on Friday . The company traded as high as GBX 383.50 ($4.84) and last traded at GBX 381.97 ($4.82). 19,355,100 shares traded hands during mid-day trading, a decline of 1% from the average session volume of 19,493,533 shares. The stock had previously closed at GBX 380.60 ($4.80).

Haleon Stock Up 0.4 %

The firm’s 50-day simple moving average is GBX 374.30 and its 200 day simple moving average is GBX 362.40. The company has a debt-to-equity ratio of 54.18, a quick ratio of 0.93 and a current ratio of 0.84. The stock has a market capitalization of £34.53 billion, a P/E ratio of 3,183.08, a PEG ratio of 1.49 and a beta of 0.19.

Insider Buying and Selling at Haleon

In other Haleon news, insider Dawn Allen sold 74,679 shares of the firm’s stock in a transaction on Thursday, November 21st. The stock was sold at an average price of GBX 372 ($4.70), for a total transaction of £277,805.88 ($350,632.18). Also, insider Alan Stewart purchased 33,923 shares of the firm’s stock in a transaction that occurred on Wednesday, November 6th. The stock was bought at an average price of GBX 368 ($4.64) per share, for a total transaction of £124,836.64 ($157,562.34). Corporate insiders own 10.74% of the company’s stock.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.